pSivida Corp. Share Price Nasdaq

Stocks

09/16/09	PSivida : Primary Endpoint Met in pSivida's Utilization Study of New Medidur™ Inserter with Smaller Diameter Needle	PU
14/16/14	PSivida : Investigator-Sponsored Phase 2 Study Results Show pSivida's Medidur® Fully Controlled Uveitis for Two Years with No Recurrence of Disease While Visual Acuity Continued to Improve	PU
02/16/02	PSivida : Medidur for Posterior Uveitis Granted Orphan Drug Designation in Europe	PU
28/15/28	PSivida : Announces NDA for Medidur™ Now Planned Using Six-Month Efficacy Data from Both Phase III Trials; FDA Concurs	BU
14/15/14	PSivida : CEO to Present at Ladenburg Thalmann 2015 Healthcare Conference September 29, 2015	BU

1 day

-0.87%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PSIVIDA CORP.	-0.87%	-2.40%	-	-	0
WUXI APPTEC CO., LTD.	-7.17%	-4.39%	+45.51%	+79.00%	5.21TCr
ARGENX SE	+0.24%	-1.54%	+53.22%	+71.85%	5.38TCr
INSMED INCORPORATED	+0.80%	-6.31%	+3.98%	+423.29%	2.35TCr
BIONTECH SE	-0.09%	-0.01%	-17.62%	-14.67%	2.31TCr
WUXI BIOLOGICS (CAYMAN) INC.	-5.95%	-2.58%	+30.67%	-9.58%	1.94TCr
GENMAB A/S	-1.14%	+0.03%	+31.57%	-30.42%	1.76TCr
PHARMAESSENTIA CORPORATION	-5.16%	-7.00%	+168.44%	+306.37%	1.52TCr
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-6.91%	-5.83%	+26.53%	+636.97%	1.48TCr
EXELIXIS, INC.	+0.43%	-1.03%	+24.63%	+191.40%	1.41TCr
Average	-2.58%	-2.62%	+40.77%	+183.80%	2.6TCr
Weighted average by Cap.	-2.80%	-2.36%	+40.12%	+144.11%